Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Oncology
Authors: María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Norma Gutiérrez, Ana-Isabel Teruel, Raquel de Paz, José García-Laraña, Enrique Bengoechea, Alejandro Martín, Joaquín Díaz Mediavilla, Luis Palomera, Felipe de Arriba, Yolanda González, Jose-Mariano Hernández, Ana Sureda, José-Luis Bello, Joan Bargay, Francisco-Javier Peñalver, José-María Ribera, María-Luisa Martín-Mateos, Ramón García-Sanz, María-Teresa Cibeira, María-Luisa Martín Ramos, María-Belén Vidriales, Bruno Paiva, María-Angeles Montalbán, Juan-José Lahuerta, Joan Bladé, Jesús-Fernando San Miguel
Institutions: Complejo Hospitalario de Salamanca, Hospital Universitario 12 De Octubre, Hospital Clínico Universitario de Valencia, Hospital Universitario La Paz, Hospital Universitario Ramón y Cajal, Donostiako Unibertsitate Ospitalea, Hospital Virgen de la Concha, Hospital Clínico San Carlos, Hospital Clínico Universitario Lozano Blesa, Hospital General Universitario Morales Meseguer, Hospital Universitari de Girona Doctor Josep Trueta, Hospital General De Segovia, Hospital de Sant Pau, Universidade de Santiago de Compostela, Hospital Son Llatzer, Hospital Universitario Fundación Alcorcón, Hospital San Pedro de Alcántara, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Johnson and Johnson
OpenAlex ID: W2134902298